Human RPA activates BLM's bidirectional DNA unwinding from a nick

  1. Zhenheng Qin
  2. Lulu Bi
  3. Xi-Miao Hou
  4. Siqi Zhang
  5. Xia Zhang
  6. Ying Lu
  7. Ming Li
  8. Mauro Modesti
  9. Xu-Guang Xi  Is a corresponding author
  10. Bo Sun  Is a corresponding author
  1. ShanghaiTech University, China
  2. Northwest A&F University, China
  3. Chinese Academy of Sciences, China
  4. Cancer Research Center of Marseille, CNRS UMR7258, Inserm U1068, France
  5. Ecole Normale Supérieure de Cachan, France

Abstract

BLM is a multifunctional helicase that plays critical roles in maintaining genome stability. It processes distinct DNA substrates, but not nicked DNA, during many steps in DNA replication and repair. However, how BLM prepares itself for diverse functions remains elusive. Here, using a combined single-molecule approach, we find that a high abundance of BLMs can indeed unidirectionally unwind dsDNA from a nick when an external destabilizing force is applied. Strikingly, human replication protein A (hRPA) not only ensures that limited quantities of BLMs processively unwind nicked dsDNA under a reduced force but also permits the translocation of BLMs on both intact and nicked ssDNAs, resulting in a bidirectional unwinding mode. This activation necessitates BLM targeting on the nick and the presence of free hRPAs in solution whereas direct interactions between them are dispensable. Our findings present novel DNA unwinding activities of BLM that potentially facilitate its function switching in DNA repair.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 3, 4 and 5.

Article and author information

Author details

  1. Zhenheng Qin

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Lulu Bi

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Xi-Miao Hou

    College of Life Sciences, Northwest A&F University, Yangling, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Siqi Zhang

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Xia Zhang

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Ying Lu

    Institute of Physics, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Ming Li

    Institute of Physics, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Mauro Modesti

    Cancer Research Center of Marseille, CNRS UMR7258, Inserm U1068, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4964-331X
  9. Xu-Guang Xi

    Laboratoire de Biologie et Pharmacologie Appliquée, Ecole Normale Supérieure de Cachan, Cachan, France
    For correspondence
    xxi01@ens-cachan.fr
    Competing interests
    The authors declare that no competing interests exist.
  10. Bo Sun

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    For correspondence
    sunbo@shanghaitech.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4590-7795

Funding

Ministry of Science and Technology of the People's Republic of China (2016YFA0500902)

  • Bo Sun

Ministry of Science and Technology of the People's Republic of China (2017YFA0106700)

  • Bo Sun

The Natural Science Foundation of Shanghai (19ZR1434100)

  • Bo Sun

The French National Cancer Institute (PLBIO2017-167)

  • Mauro Modesti

The French National League Against Cancer (EL2028.LNCC/MaM)

  • Mauro Modesti

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Qin et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,931
    views
  • 547
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhenheng Qin
  2. Lulu Bi
  3. Xi-Miao Hou
  4. Siqi Zhang
  5. Xia Zhang
  6. Ying Lu
  7. Ming Li
  8. Mauro Modesti
  9. Xu-Guang Xi
  10. Bo Sun
(2020)
Human RPA activates BLM's bidirectional DNA unwinding from a nick
eLife 9:e54098.
https://doi.org/10.7554/eLife.54098

Share this article

https://doi.org/10.7554/eLife.54098

Further reading

    1. Structural Biology and Molecular Biophysics
    Gabriel E Jara, Francesco Pontiggia ... Dorothee Kern
    Research Article

    Transition-state (TS) theory has provided the theoretical framework to explain the enormous rate accelerations of chemical reactions by enzymes. Given that proteins display large ensembles of conformations, unique TSs would pose a huge entropic bottleneck for enzyme catalysis. To shed light on this question, we studied the nature of the enzymatic TS for the phosphoryl-transfer step in adenylate kinase by quantum-mechanics/molecular-mechanics calculations. We find a structurally wide set of energetically equivalent configurations that lie along the reaction coordinate and hence a broad transition-state ensemble (TSE). A conformationally delocalized ensemble, including asymmetric TSs, is rooted in the macroscopic nature of the enzyme. The computational results are buttressed by enzyme kinetics experiments that confirm the decrease of the entropy of activation predicted from such wide TSE. TSEs as a key for efficient enzyme catalysis further boosts a unifying concept for protein folding and conformational transitions underlying protein function.

    1. Structural Biology and Molecular Biophysics
    Joseph Clayton, Aarion Romany ... Jana Shen
    Research Article

    Aberrant signaling of BRAFV600E is a major cancer driver. Current FDA-approved RAF inhibitors selectively inhibit the monomeric BRAFV600E and suffer from tumor resistance. Recently, dimer-selective and equipotent RAF inhibitors have been developed; however, the mechanism of dimer selectivity is poorly understood. Here, we report extensive molecular dynamics (MD) simulations of the monomeric and dimeric BRAFV600E in the apo form or in complex with one or two dimer-selective (PHI1) or equipotent (LY3009120) inhibitor(s). The simulations uncovered the unprecedented details of the remarkable allostery in BRAFV600E dimerization and inhibitor binding. Specifically, dimerization retrains and shifts the αC helix inward and increases the flexibility of the DFG motif; dimer compatibility is due to the promotion of the αC-in conformation, which is stabilized by a hydrogen bond formation between the inhibitor and the αC Glu501. A more stable hydrogen bond further restrains and shifts the αC helix inward, which incurs a larger entropic penalty that disfavors monomer binding. This mechanism led us to propose an empirical way based on the co-crystal structure to assess the dimer selectivity of a BRAFV600E inhibitor. Simulations also revealed that the positive cooperativity of PHI1 is due to its ability to preorganize the αC and DFG conformation in the opposite protomer, priming it for binding the second inhibitor. The atomically detailed view of the interplay between BRAF dimerization and inhibitor allostery as well as cooperativity has implications for understanding kinase signaling and contributes to the design of protomer selective RAF inhibitors.